$762k R&D Tax Incentive Received
Filed with ASX · · 1 page · English
Summary by 6ix AI
Echo IQ Limited has announced the receipt of a significant tax incentive under the Australian Government’s R&D Tax Incentive Scheme, amounting to a substantial sum. This funding recognizes the company's expenditures on research and development related to artificial intelligence innovations for detecting structural heart disease. The incentive is part of a government program designed to support eligible companies engaged in R&D activities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from EchoIQ
- Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
- QuarterlyActivities Report and Appendix 4C Cash Flow Report
- EchoSolv AS deployed into Mount Sinai Health System
- Agreement with Mayo Clinic for EchoSolv HF
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
Later from EchoIQ
- Research collaboration secured with Mayo Clinic
- EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
- Binding HOA secured with Pro Medicus Limited
- Echo IQ Raises A$110m via Institutional Placement
- Exclusive Imaging Dataset Strengthens AI Competitive Moat
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ